Evidence map›Paper›PMID 39776004›Full record

ArticleFood and environmental virology2025

Environmental Dissemination of SARS-CoV-2: An Analysis Employing Crassphage and Next-Generation Sequencing Protocols.

André Vinicius Costa Ribeiro, Camille Ferreira Mannarino, Thiago Dos Santos Leal, Carla Santos de Oliveira, Kayo Bianco, Maysa Mandetta Clementino, Shênia Patricia Corrêa Novo, Tatiana Prado, Eduardo da Silva Gomes de Castro, André Lermontov and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Food and environmental virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

André Vinicius Costa RibeiroStricto Sensu Graduate Program in Cellular and Molecular Biology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil. andre.ribeiro@fiocruz.br.ORCID 0000-0003-0779-1653
Camille Ferreira MannarinoLaboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Thiago Dos Santos LealNiterói City Hall/Secretariat for Environment, Water Resources and Sustainability, Niterói, 24020-206, Brazil.
Carla Santos de OliveiraLaboratory of Arbovirus and Hemorrhagic Virus, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Kayo BiancoNational Institute of Quality Control in Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Maysa Mandetta ClementinoNational Institute of Quality Control in Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Shênia Patricia Corrêa NovoLaboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Tatiana PradoLaboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Eduardo da Silva Gomes de CastroRio de Janeiro Federal Institute of Education, Science and Technology, Nilópolis, Rio de Janeiro, RJ, CEP 26530-060, Brazil.
André LermontovFederal University of Rio de Janeiro, Av. Athos da Silveira Ramos, 149 - Cidade Universitária, Rio de Janeiro, 21941-909, Brazil.
Tulio Machado FumianLaboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.
Marize Pereira MiagostovichLaboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-360, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico CNPq 305737/2023-6Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro Faperj-E-26/211.311/2021Instituto Oswaldo Cruz PAEF3
6 · The paper itself

Abstract

This study aimed to investigate the dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in water samples obtained during the coronavirus disease 2019 pandemic period, employing cross-assembly phage (crAssphage) as a fecal contamination biomarker and next-generation sequencing protocols to characterize SARS-CoV-2 variants. Raw wastewater and surface water (stream and sea) samples were collected for over a month in Rio de Janeiro, Brazil. Ultracentrifugation and negatively charged membrane filtration were employed for viral concentration of the wastewater and surface water samples, respectively. Viruses were detected and quantified by (RT-)qPCR applying TaqMan® system protocols. SARS-CoV-2 RNA signals were detected in 92.5% (37/40) of the wastewater samples and in 31.25% (10/32) of the stream water samples, but not in seawater samples. CrAssphage was detected in 100% of the wastewater samples, 93.75% (30/32) of the stream samples, and in 2/4 of the seawater samples. CrAssphage detection and high concentrations in stream surface waters (median 8.95 log

Indexed as

COVID-19High-Throughput Nucleotide SequencingSARS-CoV-2WastewaterBacteriophagesBrazilGenome, ViralHumansRNA, ViralSeawaterRNA, ViralWastewatercrAssphageNext-generation sequencingSARS-CoV-2SeawaterStream waterWastewater

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.